Download INTEGRATED PATHOPHYSIOLOGY BTECH TEST 1 AUGUST 2007

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

IgA nephropathy wikipedia , lookup

Transcript
INTEGRATED PATHOPHYSIOLOGY
BTECH
TEST 1 AUGUST 2007
QUESTION ONE
For questions 1.1. – 1.10 refer to the data projector slides
(15)
QUESTION TWO
2.1 Match the disease characteristics in column A with the correct glomerular disease in column B.
A
A. Occurs in Goodpasture’s syndrome
B. Is associated with a granular
immunofluorescent pattern in the basement
membrane
C. There is interstitial fibrosis and tubular
atrophy
D. “Rail track” appearance of basement
membrane on EM
E. Subendothelial deposits of C3 and IgG
B
MEMBRANOUS GN
MESANGIOCAPILLARY GN (TYPE 1& 2)
RAPIDLY PROGRESSIVE GN
CHRONIC GN
ACUTE DIFFUSE PROLIFERATIVE GN
(5)
2.2 A clinical study is performed involving subjects with glomerulonephritis. One group of subjects
has a diagnosis of crescentic glomerulonephritis and another group has membranous
glomerulonephritis. Which one of the following laboratory findings is most likely to be found in the
absence of other findings in subjects with membranous glomerulonephritis?
a. Rapid onset
b. Red blood cell casts
c. Oliguria
d. Albuminuria
e. Hypertension
(1)
2.3 Outline the features of nephritic syndrome.
(5)
2.4 List three (3) factors that affect the rate of urine production.
(3)
2.5 By means of a table match the clinical finding with the appropriate renal syndrome.
A
A. Recent onset of azotaemia
B. Pyuria
C. Renal colic
D. Asymptomatic haematuria
E. prolonged uraemia
F. Heavy protienuria
B
NEPHROTIC SYNDROME
CHRONIC RENAL FAILURE
URINARY TRACT INFECTIONS
ACUTE RENAL FAILURE
NEPHROLITHIASIS
MILD GLOMERULAR DISEASE
(6)
2.6 By means of a pencil sketch indicate the electron microscopy for ADPGN.
(4)
2.7 A 50-year-old man is hospitalized for acute myocardial infarction. He has decreased cardiac
output with hypotension requiring multiple pressor agents. His urine output drops over the next 3
days. His serum urea nitrogen increases to 59 mg/dL, with creatinine of 2.9 mg/dL. Urinalysis
reveals no protein or glucose, a trace blood, and numerous hyaline casts. Five days later, he
develops polyuria and his serum urea nitrogen declines. Which of the following pathologic findings
in his kidneys is most likely to have caused his azotemia?
a. Patchy tubular necrosis
b. Fusion of podocyte foot processes
c. Glomerular crescents
d. Hyperplastic arteriolosclerosis
e. Mesangial immune complex deposition
2.8 Discuss the pathogenesis of glomerular nephritis.
(1)
(15)
2.9 Define the following terms:
a. Diffuse glomerulosclerosis
(1)
b. Interstitial nephritis
(1)
c. Nephrocalcinosis
(1)
d. Nephrolithiasis
(1)
2.10 Study the diagrams below and answer the questions that follow:
A
B
2.10.1 The coloured in grey patches indicate areas affected by ATN. Which diagram A or B
represents ATN due to shock?
(1)
2.10.2 And which represents ATN due to toxicity?
(1)
2.10.3 Provide aetiology for 2.10.1 and 2.10.2
(2)
2.11 Discuss the oliguriac phase of ATN.
(10)
2.12 A 20-year-old previously healthy man has been feeling tired for the past 5 days. He goes to his
physician when he passes dark-colored urine. On physical examination his blood pressure is
155/90 mm Hg. Laboratory studies show his serum creatinine is 4.4 mg/dL. A urinalysis reveals pH
6, specific gravity 1.011, 3+ blood, 1+ protein, no glucose, and no ketones. On urine microscopic
examination there are numerous RBC casts. Which of the following pathologic findings on renal
biopsy is most likely to be present in this man?
a. Glomerular crescents
b. Widened proximal tubules
c. Polymorphonuclear infiltrates
d. Lipiduria
e. IgA deposited in glomerular capillaries
(1)
2.13 Name the characteristic macroscopy of malignant hypertension in the kidney and provide a
pathogenesis for each.
(6)
2.14 Discuss the pathogenesis of chronic pyelonephritis.
(12)
2.15 List three (3) complications of end stage therapies.
(3)
[95]
ADDENDUM - NORMAL VALUES
Creatinine
0.6 - 1.2 mg/dL
Glucose
Tested after fasting: 70 110 mg/dL
Hematocrit
Male: 45 - 62%
Female: 37 - 48%
Hemoglobin
Male: 13 - 18 gm/dL
Female: 12 - 16 gm/dL
Mean Corpuscular Volume (MCV)
76 - 100 cu µm
Platelet Count
150,000 - 350,000/mL
Potassium
3.5 - 5.0 mmol/L
Urea Nitrogen (BUN)
7 - 18 mg/dL
Chloride
98 - 106 mmol/L
Carbon Dioxide Pressure
35 - 45 mm Hg
Sodium
135 - 145 mEq/L
White Blood Cell Count (WBC)
4,300 - 10,800
cells/µL/cu mm
Thyroid-Stimulating Hormone (TSH)
0.5 - 6.0 µ units/mL
Bicarbonate
18 - 23 mEq/L (carbon
dioxide content)
Osmolality
280 - 296 mOsm/kg
water
Serum Alkaline Phosphatase
50 - 160 units/L
(normally higher in
infants and adolescents)
(alkaline)
Thyroxine (T4), serum
Urinalysis
Specific gravity
pH
Protein
Glucose
Ketone
Bilirubin
Blood
Nitrite
Leukocyte
Urobilinogen
RBCs
WBCs
RBC CASTS
5-12 ug/dL 64-155 nmol/L
1.002-1.030
5-7
Negative – trace
Negative
Negative
Negative
Negative
Negative
Negative
0.2-1.0 Ehr U/dL
0-2/HPF (High power field)
0-2/HPF (High Power Field)
0/HPF (High power field)